Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technologies to improve immunisation safety.

C J Clements1, M T Aguado, L Jódar

  • 1Department of Vaccines & Biologicals, Health Technology and Pharmaceuticals Cluster, World Health Organization, Geneva, Switzerland.

Drug Safety
|December 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimated number of symptomatic Lyme borreliosis cases in Germany in 2021 after adjusting for under-ascertainment.

Public health·2023
Same author

Two apparently unrelated groups of symbiotic annelids, Nautiliniellidae and Calamyzidae (Phyllodocida, Annelida), are a clade of derived chrysopetalid polychaetes.

Cladistics : the international journal of the Willi Hennig Society·2021
Same author

Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.

Advanced drug delivery reviews·2004
Same author

Breaking new ground--are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents?

Vaccine·2004
Same author

Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review.

Journal of viral hepatitis·2003
Same author

Misled and confused? Telling the public about MMR vaccine safety. Measles, mumps, and rubella.

Journal of medical ethics·2003
Same journal

Availability and Communication of Risk Management Strategies for Pregnancy Category X Medicines across Australian Medicine Information Sources.

Drug safety·2026
Same journal

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same journal

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.

Drug safety·2026
Same journal

Developing a Hierarchical Algorithm to Identify Pregnancies and Determine Gestational Age from Nationwide Linked Health Data in Taiwan.

Drug safety·2026
Same journal

Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis.

Drug safety·2026
Same journal

Analytic Misjudgment of Drug Safety Evidence and Causality: From the Prosecutor's Fallacy and Simpson's Paradox to Artificial Intelligence.

Drug safety·2026
See all related articles

Adverse events following immunization can occur due to production issues or administration errors. New technologies aim to improve vaccine safety and delivery, reducing risks for global child immunization.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Adverse events following immunization (AEFI) have been documented since the earliest vaccines.
  • Causes of adverse reactions include vaccine production faults, individual patient responses, and unsafe administration practices.

Purpose of the Study:

  • To describe technological advancements in vaccine delivery systems.
  • To outline future strategies for enhancing vaccine safety and preventing administration errors.

Main Methods:

  • Review of current and emerging vaccine administration technologies.
  • Discussion of training needs and adaptation to new technologies.

Main Results:

  • Technological innovations promise to mitigate risks associated with traditional vaccine administration.

Related Experiment Videos

  • Development of injection-free delivery systems, auto-disable syringes, and single-dose pre-filled devices are underway.
  • Mucosal and transcutaneous immunization systems are also being developed.

    • Conclusions:

    • Technological advancements are crucial for improving vaccine safety and overcoming limitations of current immunization programs.
    • Emphasis on training and adaptability to new technologies is essential for safe global childhood immunization.
    • Future strategies focus on preventing programmatic mistakes and ensuring safe vaccine delivery.